Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Conditions
- Aggressive Systemic Mastocytosis
- Mast Cell Leukemia
- Systemic Mastocytosis
Interventions
- DRUG: Brentuximab vedotin
Sponsor
Jason Robert Gotlib
Collaborators